gemcitabine 200 mg Celgem Injection

What is gemcitabine 200 mg used for?

gemcitabine 200 mg is a chemotherapeutic medication that is used to treat a variety of cancers, including bladder cancer and breast cancer. Gemcitabine may be given alone or in combination with other cancer medications, depending on your cancer type. It’s possible that you’ll need it in addition to radiotherapy.

Can Celgem Injection cure cancer?

Celgem Injection is a chemotherapeutic medicine that is used to treat malignant tumours such as ovarian cancer, lung cancer, pancreatic cancer, and breast cancer in some circumstances.

What type of chemo is Celgem Injection?

Celgem Injection is an anti-cancer chemotherapeutic medication (also known as “antineoplastic” or “cytotoxic”). Antimetabolite gemcitabine is a drug that prevents the body from metabolizing certain substances.

What is the success rate of Celgem Injection?

In 20-30% of patients, treatment with single-agent gemcitabine resulted in clinical benefit and symptom relief. While 5-fluorouracil (5-FU)-treated patients had a 2% chance of surviving one year, single-agent gemcitabine increased that to 18%.

How long can you stay on Celgem Injection?

A Celgem Injection cycle (dose) with paclitaxel lasts 21 days. On days one and eight of the cycle, gemcitabine is given. The period between each treatment cycle allows your body to heal.

Do you lose your hair with Celgem Injection?

v Hair loss with gemcitabine is usually minor, however, some people lose more hair than others. Hair growth should resume after the treatment is finished. v Nausea and vomiting are prevalent, but they are less common now than they were in the past because of better anti-nausea drugs.

Does Celgem Injection weaken the immune system?

Celgem Injection produces a significant reduction in lymphocytes, according to this study. It suppresses the humoral immune response while sparing antigen-specific cellular immunity.

Does Celgem Injection cause weight gain?

Fluid retention can occur in some patients, causing swelling in the feet, ankles, and face, as well as weight gain. Fluid can also accumulate in the lungs, causing shortness of breath. Swelling, unusual weight gain or shortness of breath should all be reported to your healthcare staff. To know more click here.

How toxic is Celgem Injection?

Celgem Injection is linked to a wide range of pulmonary toxicity, ranging from dyspnea in 25% of patients to severe pulmonary toxicity in 5% of patients.

What is the half-life of Celgem Injection?

Celgem Injection triphosphate, the active metabolite, may be isolated from peripheral blood mononuclear cells. Celgem Injection triphosphate has a half-life of 1.7 to 19.4 hours in the terminal phase in mononuclear cells.

Does Celgem Injection cause fever?

Nausea and vomiting are common side effects of gemcitabine. Chills, fever, a general feeling of unwellness, headache, muscle pain, and weakness are all flu-like symptoms.

Does Celgem Injection cause shortness of breath?

Although dyspnea is a typical side effect of Celgem Injection treatment, it is usually mild, temporary, and disease-related. In a recent study, Roychowdhury et al looked at the incidence of severe dyspnea and other serious pulmonary toxicity in 4,448 individuals who were given gemcitabine.

Does Celgem Injection cause neuropathy?

The risk of peripheral neuropathy has not been proven to be connected with gemcitabine monotherapy [96]. 5-fluorouracil (5-FU) side effects on the central nervous system were recorded in 2-5 percent of patients [97].

Does gemcitabine 200 mg cause abdominal pain?

Swelling. This medicine has caused severe and sometimes fatal liver issues in some people. If you have dark urine, are exhausted, aren’t hungry, have an upset stomach or stomach discomfort, have light-colored feces, are vomiting up, or have yellow skin or eyes, call your doctor straight once.

We are a Global wholesaler and exporter from India and operate in more than 5 countries like Oman, Qatar, UAE, Saudi, Myanmar.  If you’re looking for a different product or brand, click here.